Endoplasmic Reticulum Stress Is Associated With Autophagy and Cardiomyocyte Remodeling in Experimental and Human Atrial Fibrillation

J Am Heart Assoc. 2017 Oct 24;6(10):e006458. doi: 10.1161/JAHA.117.006458.

Abstract

Background: Derailment of proteostasis, the homeostasis of production, function, and breakdown of proteins, contributes importantly to the self-perpetuating nature of atrial fibrillation (AF), the most common heart rhythm disorder in humans. Autophagy plays an important role in proteostasis by degrading aberrant proteins and organelles. Herein, we investigated the role of autophagy and its activation pathway in experimental and clinical AF.

Methods and results: Tachypacing of HL-1 atrial cardiomyocytes causes a gradual and significant activation of autophagy, as evidenced by enhanced LC3B-II expression, autophagic flux and autophagosome formation, and degradation of p62, resulting in reduction of Ca2+ amplitude. Autophagy is activated downstream of endoplasmic reticulum (ER) stress: blocking ER stress by the chemical chaperone 4-phenyl butyrate, overexpression of the ER chaperone-protein heat shock protein A5, or overexpression of a phosphorylation-blocked mutant of eukaryotic initiation factor 2α (eIF2α) prevents autophagy activation and Ca2+-transient loss in tachypaced HL-1 cardiomyocytes. Moreover, pharmacological inhibition of ER stress in tachypaced Drosophila confirms its role in derailing cardiomyocyte function. In vivo treatment with sodium salt of phenyl butyrate protected atrial-tachypaced dog cardiomyocytes from electrical remodeling (action potential duration shortening, L-type Ca2+-current reduction), cellular Ca2+-handling/contractile dysfunction, and ER stress and autophagy; it also attenuated AF progression. Finally, atrial tissue from patients with persistent AF reveals activation of autophagy and induction of ER stress, which correlates with markers of cardiomyocyte damage.

Conclusions: These results identify ER stress-associated autophagy as an important pathway in AF progression and demonstrate the potential therapeutic action of the ER-stress inhibitor 4-phenyl butyrate.

Keywords: 4PBA; Drosophila; Endoplasmic Reticulum stress; HSPA5; atrial fibrillation; autophagy; drug research; molecular biology; structural biology; tachypacing.

MeSH terms

  • Animals
  • Atrial Fibrillation / drug therapy
  • Atrial Fibrillation / metabolism
  • Atrial Fibrillation / pathology*
  • Atrial Fibrillation / physiopathology
  • Atrial Remodeling*
  • Autophagy*
  • Calcium Channels, L-Type / metabolism
  • Calcium Signaling
  • Cardiac Pacing, Artificial
  • Cell Line
  • Disease Models, Animal
  • Dogs
  • Drosophila melanogaster
  • Endoplasmic Reticulum Chaperone BiP
  • Endoplasmic Reticulum Stress* / drug effects
  • Eukaryotic Initiation Factor-2 / genetics
  • Eukaryotic Initiation Factor-2 / metabolism
  • Female
  • Heart Atria / drug effects
  • Heart Atria / metabolism
  • Heart Atria / pathology*
  • Heart Atria / physiopathology
  • Heat-Shock Proteins / genetics
  • Heat-Shock Proteins / metabolism
  • Humans
  • Male
  • Microtubule-Associated Proteins / metabolism
  • Middle Aged
  • Mutation
  • Myocytes, Cardiac / drug effects
  • Myocytes, Cardiac / metabolism
  • Myocytes, Cardiac / pathology*
  • Phenylbutyrates / pharmacology
  • Phosphorylation
  • Proteostasis
  • Sequestosome-1 Protein / metabolism
  • Time Factors
  • Transfection

Substances

  • Calcium Channels, L-Type
  • Endoplasmic Reticulum Chaperone BiP
  • Eukaryotic Initiation Factor-2
  • HSPA5 protein, human
  • Heat-Shock Proteins
  • MAP1LC3B protein, human
  • Microtubule-Associated Proteins
  • Phenylbutyrates
  • SQSTM1 protein, human
  • Sequestosome-1 Protein
  • 4-phenylbutyric acid